Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
ACS in the Elderly
Author(s): Mansi Oberoi , Nitesh Ainani , J Dawn Abbott , et al Added: 1 year ago

MI/ACS
Added: 3 years ago
AHA Urges Action by New Congressional Leadership The American Heart Association (AHA) in November urged the new congressional leadership to increase funding for cardiovascular disease research in order to help prevent a healthcare crisis emerging with the aging of the baby boomers. With heart diseases and stroke affecting over 70 million adults in the US, rising levels of diabetes and obesity… View more

Prevention & Chronic Conditions

Standards & Guidelines
Author(s): Jindrich Spinar , Lenka Spinarová Added: 3 years ago
Acute heart failure (AHF) is a major and growing cause of in-hospital mortality in developed countries. The prevalence of HF in an unselected population >45 years of age is estimated to be 2% and in a population >65 years of age is estimated to be 8.8%.1,2 The combination of aging of the population in many countries and improved survival after acute myocardial infarction has created rapid… View more

Demographic

Heart Failure
Author(s): A Bajpai , A John Camm , I Savelieva Added: 3 years ago
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia and is characterized by unco-ordinated atrial activation with consequent loss of atrial mechanical function. In developed nations, the number of men and women affected by AF is projected to more than double over the next two decades. Despite major advances in its management, AF remains a significant cause of cardiovascular… View more

Electrophysiology & Arrhythmia
Author(s): Benjamin H Freed , Lissa Sugeng , Kathleen Furlong , et al Added: 3 years ago
Aortic stenosis (AS) is the most common valvular disease in the western hemisphere. Currently, 4% of the North American population above 75 years of age has AS, and approximately 50% of patients with mild to moderate AS will progress to hemodynamically severe AS in their lifetime.1 The natural history of the disease, which is largely unchanged since its initial description by Braunwald and Ross… View more

Vascular Disease and Surgery

Standards & Guidelines
Added: 3 years ago
HRT Linked to Heart Attack Reduction in Women Under 60 Years Hormone replacement therapy (HRT) could reduce heart attacks in women under the age of 60 by up to one-third. A study, conducted by researchers from Stanford and Cornell universities, analyzed statistical data for over 39,000 women. It uncovered that, for women who began HRT treatment to relieve menopausal symptoms whilst in their 50s,… View more

Standards & Guidelines
ENVISAGE-TAVI AF: Edoxaban noninferior to warfarin for adverse events after TAVI
Author(s): George D Dangas Added: 2 years ago
In this short video, Dr George Dangas (Mount Sinai Hospital, New York, NY, US) shares the findings from the ENVISAGE-TAVI AF hot line trial presented at ESC Congress 2021. ENVISAGE-TAVI AF (Daiichi-Sankyo) compared the safety and efficacy of the DOAC edoxaban with VKAs (warfarin and its analogues) in atrial fibrillation patients with an indication for oral anticoagulation after successful TAVI. … View more

Anticoagulation

Electrophysiology & Arrhythmia
How Old is Too Old? Closure of Patent Foramen Ovale in Older Patients
Author(s): Carlos Vazquez-Sosa , Stacey D Clegg , James C Blankenship Added: 2 years ago

Prevention & Chronic Conditions
EHRA 24: A Substudy of NOAH-AFNET 6
Author(s): Julius Nikorowitsch Added: 3 days ago
EHRA 24 - We are joined onsite by Dr Julius Nikorowitsch (University Heart and Vascular Centre Hamburg (UHZ), DE) to outline the impact of age, sex, cardiovascular comorbidities, and kidney function on outcomes with oral anticoagulation therapy in patients with device-detected atrial fibrillation in a substudy of the NOAH-AFNET 6 trial (NCT02618577).The substudy consisted of 2534 patients from… View more

Electrophysiology & Arrhythmia
TCT 23: 5 Trials That Changed My Practice
Author(s): Mirvat Alasnag Added: 5 months ago
TCT 23 - We are joined by Dr Mirvat Alasnag (The King Fahd Armed Forces Hospital, SA) for an insightful summary of the late-breaking trials that are expected to have an impact on interventional science and clinical practice. Trials covered in detail include: Agent IDE ALIGN-AR PARTNER 3 EVOLUT Low-Risk TRISCEND Recorded remotely from Jeddah, 2023. Editor: Jordan Rance Video Specialist:… View more

Intervention